Showing results (31-40 of 120) with videos related to
Sort By:
Pageof 12
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 2, 2008
Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutationsPiotr J Wysocki, Konstanty Korski, Katarzyna Lamperska, et al.Contemporary Oncology (Poznan, Poland)|February 19, 2015
Immunotargeting of cancer stem cellsEliza P Kwiatkowska-Borowczyk, Agnieszka Gąbka-Buszek, Jakub Jankowski, et al.Postepy Higieny I Medycyny Doswiadczalnej (Online)|July 8, 2011
[Engineered spider silk: the intelligent biomaterial of the future. Part I]Anna Florczak, Konrad Piekoś, Katarzyna Kaźmierska, et al.Contemporary Oncology (Poznan, Poland)|December 6, 2014
The mystery of let-7d - a small RNA with great powerTomasz Kolenda, Weronika Przybyła, Anna Teresiak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patientsEliza Kwiatkowska, Marek Teresiak, Violetta Filas, et al.International Journal of Molecular Sciences|April 3, 2021
LATS1 Is a Mediator of Melanogenesis in Response to Oxidative Stress and Regulator of Melanoma GrowthUrszula Kazimierczak, Ewelina Dondajewska, Maria Zajaczkowska, et al.Expert Opinion on Biological Therapy|October 15, 2011
Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccinesWiktoria Maria Suchorska, Hanna Dams-Kozlowska, Urszula Kazimierczak, et al.Experimental and Therapeutic Medicine|April 1, 2021
Application of a three-dimensional (3D) breast cancer model to study macrophage polarizationAgata Golabek, Mariusz Kaczmarek, Ewelina Dondajewska, et al.Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 11, 2015
Silk as an innovative biomaterial for cancer therapyKatarzyna Jastrzebska, Kamil Kucharczyk, Anna Florczak, et al.Vaccines|April 1, 2020
Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a Murine Tumor Rejection ModelAgnieszka Gąbka-Buszek, Eliza Kwiatkowska-Borowczyk, Jakub Jankowski, et al.Pageof 12